Shi V, Bhutani T, Deleuran M, Fonacier L, Shumack S, Zhang F, Cameron MC, Chan GL, Valdez H, Yin N. Abrocitinib in the Treatment of Moderate-to-Severe Atopic Dermatitis Refractory to Dupilumab Treatment: An Analysis of JADE-EXTEND, a Phase 3 Long-Term Extension Study. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s153. Available from: https://jofskin.org/33014/index.php/skin/article/view/1988